Capricor Therapeutics to Present First Quarter 2024 Financial Results and Recent Corporate Update on May 13
SAN DIEGO, May 06, 2024 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based […]